Compare Plby Group Inc (PLBY) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Plby Group Inc vs DENTSPLY SIRONA Inc — how do they compare? Plby Group Inc trades at $1.16 (market cap $141.97M), while DENTSPLY SIRONA Inc trades at $10.68 (market cap $2.19B). The key difference: DENTSPLY SIRONA Inc is far larger — about 15.4× Plby Group Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Plby Group Inc pays none. Which is the better fit depends on your goals.
| PLBY | XRAY | |
|---|---|---|
Market Cap | $141.97M | $2.19B |
Sector | Consumer Cyclical | Health |
52-Week High | $2.71 | $14.68 |
52-Week Low | $1.11 | $9.64 |
Enterprise Value | $287.56M | $4.26B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PLBY Group trades at $1.18, showing modest daily gains but remains in a technical downtrend. The company demonstrates improving fundamentals with revenue stabilizing around $120M and narrowing losses, though profitability remains elusive. Recent positive developments include Q2 2026 earnings beat, inclusion in Russell indexes, and strategic share repurchases. Analyst sentiment leans bullish with 75% buy ratings, yet technical indicators signal caution with bearish moving averages.
The outlook suggests cautious optimism as PLBY transitions toward profitability, supported by licensing growth and cost management. Key opportunities include brand monetization and market share gains, while risks involve high debt levels, negative equity, and competitive pressures. Investors should monitor execution on profitability targets and debt reduction progress for sustained recovery.
XRAY trades at $10.99, down 3.43% on the day, reflecting ongoing challenges amid a bearish technical signal. The company reported a Q2 2026 earnings beat but faces declining revenue and negative profitability, with a net income margin of -14.99%. Cash flow trends show volatility, and the debt-to-asset ratio has worsened to 42.88% in 2025. Recent news highlights margin pressure and a class-action lawsuit inquiry, clouding the near-term outlook despite some institutional buying interest.
The investment outlook is cautious. While the stock trades below the consensus price target of $12.50, persistent net losses, high debt, and competitive pressures pose significant risks. Analyst sentiment is mixed with a 'Hold' consensus, suggesting limited upside until the company demonstrates sustained operational improvement and revenue stabilization.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Plby Group Inc
PLBY Group Inc is a pleasure and leisure company. The company's segment includes Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It generates maximum revenue from the Direct-to-Consumer segment. Direct-to-Consumer operations include consumer products sold through third-party retailers or online direct-to-customer. Geographically, it derives a majority of revenue from the United States.
Read more on PLBY →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
